A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections

Recruiting Phase 1 Interventional Study
Surgical Wound Infection Traumatic Wound Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 79
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
44 (estimated)
Sponsor
Macro Biologics, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this Phase 1 clinical trial is to learn about the safety profile of Amicidin-β topical solution applied directly into infected surgical or traumatic wounds during a surgical procedure. The main questions it aims to answer are: 1. Is Amicidin-β topical solution safe to test in larger clinical trials? 2. Is Amicidin-β topical solution absorbed into the bloodstream from local wound appli…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Main Inclusion Criteria: * Body Mass Index between 18.5 kg/square meter and 39.9kg/square meter * Surgical or traumatic wound determined by the Investigator to be infected within 90 days of surgery or trauma, with longest dimension between 3 and 15 cm. The diagnosis should include one or more of th…
Contacts

Daniel J Gowen-Huang, MBA

(323) 717-0302

dgowenhuang@macrobiologics.com

CONTACT

Michael P Bevilacqua, MD, PhD

(303) 881-5169

mpb@macrobiologics.com

CONTACT